Alterations in inflammatory and coagulation variables in COVID-19 patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021581

Enrollment

100

Registered

2020-04-27

Start date

2020-04-27

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1 J18.9

Interventions

Group 1: Patients with suspected or confirmed COVID-19 infection: Blood (approx. 4ml) is drawn at hospital admission and during the hospital stay

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Written informed consent to study participation 2. Age > 18 years. 3. Confirmed or suspected COVID-19 infection with the need of in hospital care.

Exclusion criteria

Exclusion criteria: 1. Denial of the patient 2. Patients transferred from other hospitals. 3. Missing COVID-19 testing 4. prehospital intubation

Design outcomes

Primary

Measure	Time frame
Association between coagulation alterations and course of COVID-19-disease	—

Secondary

Measure	Time frame
length of hospital stay, infectious variables, death	—

Countries

Germany

Contacts

Public ContactTobias Nitschke

Klinikum der Universität München, Klinik für Anaesthesiologie

tobias.nitschke@med.uni-muenchen.de089440081223

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026